医薬品医療機器等法違反業者に対する自治体による行政処分について（第２報）｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000154867.html医薬品医療機器等法違反業者に対する自治体による行政処分について（第２報）｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces administrative measures taken by Tokyo and Osaka against wholesale pharmaceutical distributors regarding counterfeit C-type hepatitis treatment drug "Harvoni Combination Tablets." On March 13, 2017, Tokyo issued improvement orders to five companies: Yell Pharmaceutical, Daiko Pharmaceutical, Takayo Pharmaceutical, Fuji Pharmaceutical, and Nogawa Pharmaceutical. Osaka issued an order to Global Net Ells. All orders were based on the Pharmaceutical Affairs Law Article 72-4, Paragraph 1, to ensure product quality, efficacy, and safety.
